Cargando…
Severe Encephalopathy, Lactic Acidosis, Vegetative Instability and Neuropathy with 5-Fluorouracil Treatment – Pyrimidine Degradation Defect or Beriberi?
We present the case of a 19-year-old female with nasopharyngeal carcinoma, who received two courses of chemotherapy with 5-fluorouracil (5-FU) in combination with folic acid and cisplatin. Upon developing esophageal strictures in the course of her radiotherapy, she required total parenteral nutritio...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177792/ https://www.ncbi.nlm.nih.gov/pubmed/21941485 http://dx.doi.org/10.1159/000328803 |
_version_ | 1782212328350023680 |
---|---|
author | Rosen, A. van Kuilenburg, A. Assmann, B. Kuhlen, M. Borkhardt, A. |
author_facet | Rosen, A. van Kuilenburg, A. Assmann, B. Kuhlen, M. Borkhardt, A. |
author_sort | Rosen, A. |
collection | PubMed |
description | We present the case of a 19-year-old female with nasopharyngeal carcinoma, who received two courses of chemotherapy with 5-fluorouracil (5-FU) in combination with folic acid and cisplatin. Upon developing esophageal strictures in the course of her radiotherapy, she required total parenteral nutrition. In the course of therapy, the patient developed severe multisystem failure with encephalopathy, lactic acidosis, vegetative instability and neuropathy. The treatment with 5-FU can lead to severe toxicity due to enzyme deficiencies in the degradation of pyrimidines, but it can also lead to thiamine deficiency with the classic symptoms of beriberi. Beriberi is a rare disorder, usually attributed to malnutrition or alcoholism. 5-FU has been shown to induce thiamine depletion. Reduced food intake or total parenteral nutrition devoid of vitamin supplements may aggravate symptoms. We were unable to find a genetic cause for increased 5-FU toxicity in our patient, ruling out deficiencies of dihydropyrimidine dehydrogenase, dihydropyrimidinase or β-ureidopropionase and double-strand break repair deficits. We come to the conclusion that, even without any definable enzyme deficiency, treatment with 5-FU can lead to high toxicity due to thiamine deficiency if vitamin supplementation is not undertaken. |
format | Online Article Text |
id | pubmed-3177792 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-31777922011-09-22 Severe Encephalopathy, Lactic Acidosis, Vegetative Instability and Neuropathy with 5-Fluorouracil Treatment – Pyrimidine Degradation Defect or Beriberi? Rosen, A. van Kuilenburg, A. Assmann, B. Kuhlen, M. Borkhardt, A. Case Rep Oncol Published: August 2011 We present the case of a 19-year-old female with nasopharyngeal carcinoma, who received two courses of chemotherapy with 5-fluorouracil (5-FU) in combination with folic acid and cisplatin. Upon developing esophageal strictures in the course of her radiotherapy, she required total parenteral nutrition. In the course of therapy, the patient developed severe multisystem failure with encephalopathy, lactic acidosis, vegetative instability and neuropathy. The treatment with 5-FU can lead to severe toxicity due to enzyme deficiencies in the degradation of pyrimidines, but it can also lead to thiamine deficiency with the classic symptoms of beriberi. Beriberi is a rare disorder, usually attributed to malnutrition or alcoholism. 5-FU has been shown to induce thiamine depletion. Reduced food intake or total parenteral nutrition devoid of vitamin supplements may aggravate symptoms. We were unable to find a genetic cause for increased 5-FU toxicity in our patient, ruling out deficiencies of dihydropyrimidine dehydrogenase, dihydropyrimidinase or β-ureidopropionase and double-strand break repair deficits. We come to the conclusion that, even without any definable enzyme deficiency, treatment with 5-FU can lead to high toxicity due to thiamine deficiency if vitamin supplementation is not undertaken. S. Karger AG 2011-08-10 /pmc/articles/PMC3177792/ /pubmed/21941485 http://dx.doi.org/10.1159/000328803 Text en Copyright © 2011 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions. |
spellingShingle | Published: August 2011 Rosen, A. van Kuilenburg, A. Assmann, B. Kuhlen, M. Borkhardt, A. Severe Encephalopathy, Lactic Acidosis, Vegetative Instability and Neuropathy with 5-Fluorouracil Treatment – Pyrimidine Degradation Defect or Beriberi? |
title | Severe Encephalopathy, Lactic Acidosis, Vegetative Instability and Neuropathy with 5-Fluorouracil Treatment – Pyrimidine Degradation Defect or Beriberi? |
title_full | Severe Encephalopathy, Lactic Acidosis, Vegetative Instability and Neuropathy with 5-Fluorouracil Treatment – Pyrimidine Degradation Defect or Beriberi? |
title_fullStr | Severe Encephalopathy, Lactic Acidosis, Vegetative Instability and Neuropathy with 5-Fluorouracil Treatment – Pyrimidine Degradation Defect or Beriberi? |
title_full_unstemmed | Severe Encephalopathy, Lactic Acidosis, Vegetative Instability and Neuropathy with 5-Fluorouracil Treatment – Pyrimidine Degradation Defect or Beriberi? |
title_short | Severe Encephalopathy, Lactic Acidosis, Vegetative Instability and Neuropathy with 5-Fluorouracil Treatment – Pyrimidine Degradation Defect or Beriberi? |
title_sort | severe encephalopathy, lactic acidosis, vegetative instability and neuropathy with 5-fluorouracil treatment – pyrimidine degradation defect or beriberi? |
topic | Published: August 2011 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177792/ https://www.ncbi.nlm.nih.gov/pubmed/21941485 http://dx.doi.org/10.1159/000328803 |
work_keys_str_mv | AT rosena severeencephalopathylacticacidosisvegetativeinstabilityandneuropathywith5fluorouraciltreatmentpyrimidinedegradationdefectorberiberi AT vankuilenburga severeencephalopathylacticacidosisvegetativeinstabilityandneuropathywith5fluorouraciltreatmentpyrimidinedegradationdefectorberiberi AT assmannb severeencephalopathylacticacidosisvegetativeinstabilityandneuropathywith5fluorouraciltreatmentpyrimidinedegradationdefectorberiberi AT kuhlenm severeencephalopathylacticacidosisvegetativeinstabilityandneuropathywith5fluorouraciltreatmentpyrimidinedegradationdefectorberiberi AT borkhardta severeencephalopathylacticacidosisvegetativeinstabilityandneuropathywith5fluorouraciltreatmentpyrimidinedegradationdefectorberiberi |